Osteoporosis
Cleveland Clinic launches multispecialty center focused on midlife women
Cleveland Clinic has launched a holistic health center focused exclusively on caring for midlife women, addressing a wide range of needs from osteoporosis and breast health to CVD prevention and the menopause transition.
Pregnancy and lactation-associated osteoporosis incidence higher than previously reported
Pregnancy and lactation-associated osteoporosis incidence was greater than previously reported, suggesting potentially overlooked patients, with vertebral fracture the most common type of premenopausal osteoporosis, researchers reported.
USPSTF: Screen older and at-risk postmenopausal women for osteoporosis
The U.S. Preventive Services Task Force has issued a draft recommendation stating that all women aged 65 years and older be screened for osteoporosis to prevent fractures.
Diabetes rates on the rise for women aged 50 years and older with osteoporosis
BOSTON — The percentage of women with osteoporosis who also had diabetes increased from 2009-2010 to 2017-2018, despite a decline in overall diabetes rates for women aged 50 years and older, according to data presented at ENDO 2024.
Q&A: At 20 years, WHI emphasizes personalized postmenopausal care, shared decision-making
Results of Women’s Health Initiative trials highlight the importance of personalized health care in combination with shared decision-making for postmenopausal women, according to a review published in JAMA.
Diabetes does not raise risk for subsequent hip fracture after incident fracture
Older adults with type 1 or type 2 diabetes who sustain an incident hip fracture have a similar likelihood for a subsequent hip fracture as those without diabetes, according to study data published in Bone.
‘Be prepared to negotiate’ with patients when choosing osteoporosis treatment
DESTIN, Fla. — Individualized treatment for osteoporosis calls for a keen understanding of the patient’s frame of mind, according to a speaker at the Congress of Clinical Rheumatology East.
Anabolic, antiresorptive agents the 'ideal one-two punch' for osteoporosis
DESTIN, Fla. — Patients with osteoporosis may benefit from treatment initiation with an anabolic agent followed by an antiresorptive agent, according to a speaker at the Congress of Clinical Rheumatology East.
Most providers start osteoporosis therapy without full assessment of secondary causes
NEW ORLEANS —Few providers conduct a complete assessment of secondary causes of osteoporosis before initiating medication, according to findings presented at the AACE annual meeting.
Most providers start osteoporosis therapy without full assessment of secondary causes
NEW ORLEANS —Few providers conduct a complete assessment of secondary causes of osteoporosis before initiating medication, according to findings presented at the AACE annual meeting.